Form D · Biotechnology
EXELIXIS INC
South San Francisco, CA · CIK 0000939767
Offering snapshot reported Jul 16, 2009 · SEC filing
- Reported sold
- $0 Offering amount: $3.03M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 10, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 16, 2009 | Initial | $0 | No comparison | 1 | SEC filing |
| Jun 27, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 3, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 1, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-93976-7L
Represents the exercise price of the warrant to purchase common stock. The issuer will not receive such purchase price unless the warrant holder exercises such warrant in exchange for shares of common stock.
Source: Form D, filed Jul 16, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Charles Cohen | Director |
| Carl B. Feldbaum | Director |
| Alan M. Garber | Director |
| Frances K. Heller | Executive |
| Frank L. Karbe | Executive |
| Peter Lamb | Executive |
| Vincent T. Marchesi | Director |
| Frank Mc Cormick | Director |
| Michael M. Morrissey | Executive |
| Stelios Papadopoulos | Director |
| George Poste | Director |
| Lupe M. Rivera | Executive |
| George A. Scangos | Director, Executive |
| Gisela M. Schwab | Executive |
| Pamela A. Simonton | Executive |
| Lance Willsey | Director |
| Jack L. Wyszomierski | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
249 East Grand Ave.
South San Francisco, CA, 94083-0511
South San Francisco, CA, 94083-0511